InsidersTradesSigma
Browse the complete record of transactions filed by Frattaroli Joseph, 首席财务官. Officer active across 1 company, notably Inhibikase Therapeutics, Inc.. In total, 1 filings have been recorded. Split: 1 buy · 0 sell. Total volume traded: €2k. Activity tracked since 19 May 2022. The latest transaction was filed on 19 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Frattaroli Joseph is the Chief Financial Officer at Inhibikase Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is essential to support the company's growth and profitability.